Pulfibro Tablet 534 mg contains Pirfenidone, an antifibrotic and anti-inflammatory agent used for the management of idiopathic pulmonary fibrosis (IPF). IPF is a chronic, progressive lung disease characterized by scarring (fibrosis) of the lung tissue, leading to reduced lung function, breathlessness, and decreased exercise capacity. Pulfibro helps slow the progression of fibrosis, preserve lung function, and improve the quality of life for patients living with this condition.

Pirfenidone works at the cellular level by inhibiting the pathways responsible for fibrotic tissue formation and inflammation. Regular use of Pulfibro Tablet 534 mg can reduce the decline in lung function, manage disease-related symptoms, and help patients maintain better respiratory health over time. This intermediate-dose tablet is typically used as part of a titration schedule to reach optimal therapeutic doses safely and effectively.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each tablet contains:

• Pirfenidone – 534 mg

Mechanism of Action

Pirfenidone exerts antifibrotic and anti-inflammatory effects by targeting multiple mechanisms involved in IPF:

• Inhibits fibroblast proliferation and collagen production, preventing excessive scarring in lung tissue

• Reduces pro-fibrotic cytokines, including transforming growth factor-beta (TGF-β)

• Modulates inflammatory processes that contribute to lung tissue damage

Through these actions, Pulfibro helps slow the progression of IPF, allowing patients to maintain lung function and physical activity for longer periods.

Indications

Pulfibro Tablet 534 mg is indicated for:

• Treatment of idiopathic pulmonary fibrosis (IPF) in adults

• Slowing the progression of lung fibrosis and preserving lung function in patients with mild to moderate IPF

• Management of symptoms associated with IPF, including breathlessness, fatigue, and reduced exercise tolerance

It is important to note that Pulfibro does not cure IPF, but it helps reduce the rate of disease progression and improve long-term outcomes.

Dosage and Administration

Pulfibro Tablet should be used as prescribed by a healthcare professional:

• Usually administered as part of a dose titration schedule to reach a full therapeutic dose

• Take orally with food to improve absorption and reduce gastrointestinal discomfort

• Follow the prescribed dosage schedule strictly

• Do not alter the dose without consulting a healthcare provider

Benefits

• Slows the progression of idiopathic pulmonary fibrosis

• Reduces lung tissue scarring and fibrosis

• Preserves lung function and improves exercise tolerance

• Supports long-term quality of life for patients with IPF

• Clinically proven efficacy and safety in IPF management

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects may include:

• Nausea, vomiting, or loss of appetite

• Fatigue or dizziness

• Rash or increased sensitivity to sunlight

• Liver enzyme elevations

Severe or persistent side effects should be reported to a physician promptly. Regular liver function monitoring is recommended during treatment.

Precautions

• Use with caution in patients with liver or kidney impairment

• Avoid excessive sun exposure due to photosensitivity

• Not suitable for acute respiratory infections or sudden exacerbations

• Inform your physician of all current medications to avoid interactions

• Pregnant or breastfeeding women should consult a doctor before use

Storage

Store in a cool, dry place, protected from light and moisture. Keep out of reach of children.